Indication
Neonatal Encephalopathy
8 clinical trials
11 products
1 drug
Product
Normal SalineProduct
SovateltideClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase-II Trial to Assess Safety, and Efficacy of Sovateltide in the Treatment of Hypoxic-ischemic Encephalopathy in NeonatesStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Darbepoetin in Neonatal Encephalopathy (EDEN) TrialStatus: Recruiting, Estimated PCD: 2024-09-01
Product
Darbepoetin AlfaClinical trial
Mild Encephalopathy in the Newborn Treated With Darbepoetin (MEND)Status: Completed, Estimated PCD: 2019-12-01
Drug
VarlilumabClinical trial
Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia: A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy (Phase II Study)Status: Not yet recruiting, Estimated PCD: 2027-10-01
Product
SildenafilProduct
Ora-BlendClinical trial
A Phase IIb Dose Escalation Study of Levetiracetam for the Treatment of Neonatal SeizuresStatus: Recruiting, Estimated PCD: 2026-07-01
Product
LevetiracetamProduct
Phenobarbital SodiumClinical trial
Prevention of Epilepsy by Reducing Neonatal EncephalopathyStatus: Active (not recruiting), Estimated PCD: 2024-08-01
Product
Intra-partum care bundleClinical trial
Contrast Enhanced Ultrasound and Elastography of the Neonatal BrainStatus: Not yet recruiting, Estimated PCD: 2029-07-01
Product
Sulfur HexafluorideClinical trial
High-dose Erythropoietin for Asphyxia and EncephalopathyStatus: Completed, Estimated PCD: 2021-10-01
Product
Normal salineProduct
Erythropoietin